Analyst Ranking
Top 5%
#209 out of 4873 analysts
Average Return
+25.42%
Win Rate
37%45 out of 122
Risk vs Reward
Poor
Good

Mayank Mamtani's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Novavax IncNVAX
+1,295.56%$13.05$182.12
2020-03-26 -
2021-03-26
Strong Buy
Novavax IncNVAX
+946.95%$19.83$207.61
2020-04-23 -
2021-04-23
Strong Buy
Tg Therapeutics IncTGTX
+534.38%$4.13$26.20
2022-06-12 -
2023-06-12
Strong Buy
Cymabay Therapeutics IncCBAY
+382.37%$1.90$9.17
2022-05-17 -
2023-05-17
Strong Buy
Tg Therapeutics IncTGTX
+245.33%$6.75$23.31
2023-10-19 -
2024-10-18
Strong Buy

Mayank Mamtani's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Madrigal Pharmaceuticals IncMDGL
9Strong Buy$460.00+53.55%Reiterates
7 days ago
Harrow IncHROW
2Strong Buy$65.00+175.54%Maintains
a month ago
Vaxart IncVXRT
5Strong Buy$2.00+391.40%Maintains
a month ago
Trevi Therapeutics IncTRVI
3Strong Buy$20.00+203.03%Reiterates
2 months ago
Lineage Cell Therapeutics IncLCTX
2Strong Buy$3.00+538.30%Maintains
2 months ago
Denali Therapeutics IncDNLI
2Strong Buy$35.00+142.55%Reiterates
2 months ago
Arrowhead Pharmaceuticals IncARWR
7Strong Buy$38.00+186.79%Reiterates
3 months ago
Viking Therapeutics IncVKTX
2Strong Buy$96.00+244.70%Reiterates
3 months ago
Nektar TherapeuticsNKTR
1Strong Buy$4.00+546.20%Initiates Coverage On
4 months ago
Cognition Therapeutics IncCGTX
3Strong Buy$1.50+354.55%Upgrades
5 months ago
Novavax IncNVAX
16Strong Buy$26.00+290.39%Reiterates
7 months ago
Gritstone Bio IncGRTSQ
4Hold$1.00+3,025.00%Downgrades
7 months ago
Centessa Pharmaceuticals PLCCNTA
1Strong Buy$33.00+166.34%Initiates Coverage On
8 months ago
Altimmune IncALT
8Strong Buy$20.00+244.83%Reiterates
9 months ago
Tg Therapeutics IncTGTX
11Strong Buy$34.00+0.41%Maintains
9 months ago
Macrogenics IncMGNX
1Hold$5.00+224.68%Downgrades
9 months ago
Cytokinetics IncCYTK
3Strong Buy$92.00+183.25%Maintains
a year ago
Cymabay Therapeutics IncCBAY
5Hold$32.50N/ADowngrades
a year ago
Checkpoint Therapeutics IncCKPT
3Strong Buy$4.00N/AMaintains
a year ago
Ngm Biopharmaceuticals IncNGM
4Strong Buy$3.50N/AMaintains
a year ago
Scilex Holding CoSCLX
1Strong Buy$140.00N/AInitiates Coverage On
2 years ago
Intercept Pharmaceuticals IncICPT
8Hold$19.00N/ADowngrades
2 years ago
X4 Pharmaceuticals IncXFOR
5Strong Buy$90.00N/AMaintains
2 years ago
Agenus IncAGEN
1Strong Buy$160.00N/AReiterates
2 years ago
Spectrum Pharmaceuticals IncSPPI
4Hold$1.00N/ADowngrades
2 years ago
Gain Therapeutics IncGANX
3Hold$5.00N/ADowngrades
3 years ago
Cassava Sciences IncSAVA
3Strong Buy$44.00N/AMaintains
3 years ago
Fortress Biotech IncFBIO
1Strong Buy$90.00N/AMaintains
3 years ago
Inmune Bio IncINMB
2Hold$7.00N/ADowngrades
3 years ago
Tff Pharmaceuticals IncTFFP
1Strong Buy$450.00N/AMaintains
3 years ago
Korro Bio IncKRRO
1Strong Buy$10.00N/AMaintains
3 years ago
Allena Pharmaceuticals IncALNAQ
3Hold$0.50N/ADowngrades
3 years ago
Scorpius Holdings IncSCPX
1Strong Buy$8.00N/AMaintains
3 years ago
Seelos Therapeutics IncSEELQ
2Strong Buy$15,360.00N/AMaintains
3 years ago
Mustang Bio IncMBIO
3Strong Buy$4,500.00N/AMaintains
3 years ago
Biovie IncBIVI
2Strong Buy$270.00N/AMaintains
3 years ago
Eloxx Pharmaceuticals IncELOX
1Strong Buy$200.00N/AInitiates Coverage On
4 years ago
Arcturus Therapeutics Holdings IncARCT
2Hold$77.00N/ADowngrades
4 years ago
Grace Therapeutics IncGRCE
2Strong Buy$96.00N/AUpgrades
5 years ago
Galmed Pharmaceuticals LtdGLMD
3Hold$1,440.00N/ADowngrades
5 years ago
Galectin Therapeutics IncGALT
1Strong Buy$4.00N/AMaintains
5 years ago
IMV IncIMVIQ
2Hold$30.00N/ADowngrades
5 years ago
Liberty Media CorpFWONK
1Strong Buy$39.00N/AMaintains
5 years ago
Medicinova IncMNOV
1Strong Buy$11.00N/AMaintains
5 years ago
Genfit SaGNFT
1Strong Buy$34.00N/AMaintains
5 years ago
Arqule IncARQL
1Hold$20.00N/ADowngrades
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.